Latest filing published 02 Apr 2026 for CVS HEALTH Corp, €1.6M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Prem S. Shah (chief executive) discloses dealings in CVS HEALTH Corp to SEC (Form 4). We count 38 filings; the first trade dates from 21 February 2022 and the latest from 1 April 2026.
On the market, this insider has only sold: 9 sales, €4.7M in total. Other entries cover 22 share grants and 7 option exercises.
The newest entry dates from 2 April 2026: a share grant of €1.6M, in CVS HEALTH Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations